Urinary Tract Cancer: State of the Art
EORTC G4 Group Seminar. European Urology", Vol 31,. Supplement Issue: Vol. 31, Suppl. (1997): European Urology
Published on 18. February 1997
Book
Paperback/Softback
IV, 82 pages
978-3-8055-6466-3 (ISBN)
Description
This supplement issue presents advances in knowledge of the main urological cancers from a multidisciplinary perspective. It opens with an in-depth overview of controversial issues in the diagnosis and treatment of prostate cancer, followed by a paper on animal models and preliminary experience with oral bropirimine in phase I-II trials. The next four presentations focus on superficial bladder cancer, and include an overview of recent literature and results from ongoing clinical trials. Further contributions demonstrate the importance of randomized clinical trials to the care of patients with bladder cancer and provide a complete review of the diagnosis and treatment of kidney cancer. The final papers deal with important, but often ignored, subjects: quality of life, statistical design of trials and health economics. Bringing together the expertise and experience of leading authorities, this issue is valuable reading for all those interested in optimizing the treatment of patients with urinary tract cancer.
More details
Content
Prostate cancer - to screen or not to screen?, C. Bouffioux; oral bropirimine immunotherapy of rodent prostate cancer, M.F. Sarosdy; diagnosis and treatment of superficial transitional cell carcinoma of the bladder - facts and perspectives, K.H. Kurth; a review of clinical studies of bropirimine immunotherapy of carcinoma in situ of the bladder and upper urinary tract, M.F. Sarosdy; treatment of carcinoma in situ of the urinary bladder with bropirimine, J.A. Witjes; BCG update - intravesical therapy; application of clinical trials to the care of patients with bladder cancer, R.R. Hall; J.A. Martinez-Pineiro and L. Martinez-Pineiro; renal cell carcinoma - diagnosis and treatment - state of the art, A.V. Bono and J.A.J. Lovisolo; quality of life as an outcome measure in cancer clinical trials, G.M. Kiebert; an introduction to the statistical design of phase III cancer clinical trials, R. Sylvester; economics of urinary tract cancers - state of the art, N. Neymark and K. Torfs.